Scholarlink

<p><i>Polygonum multiflorum</i> (PM) has been reported to cause immune-mediated idiosyncratic liver injury. 2,3,5,4’-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) has been identified as a hepatotoxic constituent responsible for PM-induced hepatotoxicity. Covalent protein modification by reactive metabolites plays a crucial role in herb and drug-induced liver injury. Whether it is essential for the hepatotoxicity of THSG needs further clarification. THSG can be hydrolyzed into its aglycone 2,3,5,4’-tetrahydroxystilbene (THS). This study aims to investigate the impact of THS on liver injury and elucidate its underlying mechanism. Metabolism of THSG and covalent modification of cysteine residues by THS were identified by mass spectrometry and proteomics. Hepatotoxicity and T-cell immune response induced by THS were evaluated <i>in vitr</i>o and in vivo. The immunological mechanism was investigated using PBMC from healthy donors. THS was detected in both the liver and blood samples after oral administration of THSG to mice. Cysteine-based covalent modification of glutathione (GSH), glutathione S-transferase Pi (GSTP) and hepatic proteins by THS was identified. Liver injury accompanied by inflammatory cell infiltration and T-cell activation were observed i<i>n vivo</i> and in vitro with THS treatment. PBMCs from healthy donors and drug-specific T-cell clones (TCCs) could be activated by THS possibly through the hapten pathway. THS, the deglycosylated metabolite of THSG, functions as a hapten by covalently binding to proteins to induce cellular stress and activate T-cells, which may contribute to PM-induced hepatotoxicity.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The deglycosylated metabolite of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D- glucoside contributes to immune-mediated hepatotoxicity induced by Polygonum multiflorum

  • 期刊论文

  • 发表日期：

    2025年9月2日

查看全文
  • Ying Li,
  • Yuwei Hu,
  • Xiaoli Meng,
  • Paul Thomson,
  • Dongsheng Ouyang,
  • Dean Naisbitt,
  • Tai Rao

摘要

Polygonum multiflorum (PM) has been reported to cause immune-mediated idiosyncratic liver injury. 2,3,5,4’-tetrahydroxystilbene-2-O-β-D-glucoside (THSG) has been identified as a hepatotoxic constituent responsible for PM-induced hepatotoxicity. Covalent protein modification by reactive metabolites plays a crucial role in herb and drug-induced liver injury. Whether it is essential for the hepatotoxicity of THSG needs further clarification. THSG can be hydrolyzed into its aglycone 2,3,5,4’-tetrahydroxystilbene (THS). This study aims to investigate the impact of THS on liver injury and elucidate its underlying mechanism. Metabolism of THSG and covalent modification of cysteine residues by THS were identified by mass spectrometry and proteomics. Hepatotoxicity and T-cell immune response induced by THS were evaluated in vitro and in vivo. The immunological mechanism was investigated using PBMC from healthy donors. THS was detected in both the liver and blood samples after oral administration of THSG to mice. Cysteine-based covalent modification of glutathione (GSH), glutathione S-transferase Pi (GSTP) and hepatic proteins by THS was identified. Liver injury accompanied by inflammatory cell infiltration and T-cell activation were observed in vivo and in vitro with THS treatment. PBMCs from healthy donors and drug-specific T-cell clones (TCCs) could be activated by THS possibly through the hapten pathway. THS, the deglycosylated metabolite of THSG, functions as a hapten by covalently binding to proteins to induce cellular stress and activate T-cells, which may contribute to PM-induced hepatotoxicity.